Perioperative effect of methylprednisolone given during lung surgery on plasma concentrations of C3a and C5a. 1990

K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
Department of Anaesthesiology, Kobe University School of Medicine, Japan.

Methylprednisolone or saline (placebo) solution was infused intravenously in 28 patients undergoing elective lobectomy for lung cancer. The state of the complement system during and after surgery and the effects of methylprednisolone on biologically active products of complement were studied by measurements of plasma C3a and C5a anaphylatoxins and leukocyte counts in peripheral blood perioperatively. In the placebo group plasma concentrations of C3a were significantly increased on postoperative days 1 and 2, whereas C5a had risen significantly 6 hours after surgery and on days 1 and 2. Methylprednisolone infusion during surgery eliminated the postoperative elevation of C3a and C5a. The postoperative leukocyte count in peripheral blood was higher in the methylprednisolone group than in the controls. The observations indicated that methylprednisolone may reduce the influx of leukocytes from peripheral blood into the airways by attenuating production of biologically active complements.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015926 Complement C3a The smaller fragment generated from the cleavage of complement C3 by C3 CONVERTASE. C3a, a 77-amino acid peptide, is a mediator of local inflammatory process. It induces smooth MUSCLE CONTRACTION, and HISTAMINE RELEASE from MAST CELLS and LEUKOCYTES. C3a is considered an anaphylatoxin along with COMPLEMENT C4A; COMPLEMENT C5A; and COMPLEMENT C5A, DES-ARGININE. C3a Complement,Complement 3a,Complement Component 3a,C3a, Complement,Complement, C3a,Component 3a, Complement
D015936 Complement C5a The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE), smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION. C5a Complement,Complement 5a,Complement Component 5a,C5a, Complement,Complement, C5a,Component 5a, Complement

Related Publications

K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
March 1994, The Annals of thoracic surgery,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
October 1988, Nihon Kyobu Shikkan Gakkai zasshi,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
January 1978, Advances in immunology,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
June 1987, Nihon Kyobu Shikkan Gakkai zasshi,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
March 1986, Archives of surgery (Chicago, Ill. : 1960),
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
April 1977, Masui. The Japanese journal of anesthesiology,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
January 2021, Frontiers in cardiovascular medicine,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
September 1984, The Journal of pharmacology and experimental therapeutics,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
February 1986, Nihon Kyobu Shikkan Gakkai zasshi,
K Mikawa, and J Ikegaki, and N Maekawa, and H Hoshina, and O Tanaka, and R Goto, and H Obara, and M Kusunoki
February 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
Copied contents to your clipboard!